APOLLO THERAPEUTICS Trademark

Trademark Overview


On Monday, June 28, 2021, a trademark application was filed for APOLLO THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the APOLLO THERAPEUTICS trademark a serial number of 90798637. The federal status of this trademark filing is REGISTERED as of Tuesday, September 26, 2023. This trademark is owned by Apollo Therapeutics LLP. The APOLLO THERAPEUTICS trademark is filed in the Pharmaceutical Products, Advertising, Business and Retail Services, Insurance & Financial Services, Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Education services, namely, providing instruction in the field of pharmaceutical and therapeutic medical education; arranging and conducting of conferences, congresses, courses, in particular in the fields of medicine and pharmaceuticals; publishing services, namely, the publication of periodicals, books, magazines, and articles in the field of medicine, pharmaceuticals, and therapeutics; publication of periodicals, books, magazines, articles, in particular in the fields of medicine, pharmaceuticals and therapeutics

Therapeutic pharmaceuticals for the treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseases and disorders of the autoimmune system, allergies, renal transplant, hypertension, chronic kidney disease, and metabolic diseases; pharmaceutical preparations, namely biologics, biosimilars, small molecules, gene-engineered cell therapy in the nature of cells for medical use, namely autologous gene-engineered cells; medical preparations for the treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseases and disorders of the autoimmune system, allergies, renal transplant, hypertension, chronic kidney disease, and metabolic diseases

Financial sponsorship in the form of providing financial resources to non-hospital partnerships, associations and companies, to aid in the research, development, production, import, export, retail, wholesale, promotion, commercial distribution and commercialisation of pharmaceutical, therapeutic and medicinal products and preparations

Collection of data and management of data for business purposes in connection with clinical research, testing, trial and development of pharmaceuticals, therapeutics and medical devices; computerized database management and data processing services in the field of medical, pharmaceutical and therapeutic treatment

Non-emergency and non-clinical medical and pharmaceutical consulting services related to the use of pharmaceutical preparations, namely biologics, biosimilars, small molecules, gene-engineered cell therapy and vaccines; non-emergency medical analysis services for diagnostic and treatment purposes related to the use of pharmaceutical preparations, namely biologics, biosimilars, small molecules, gene-engineered cell therapy and vaccines, provided by medical laboratories; medical analysis and examination services related to the treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseases and disorders of the autoimmune system, allergies, renal transplant, hypertension, chronic kidney disease, and metabolic diseases, provided by medical laboratories; medical treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseases an...

Scientific, medical and pharmaceutical research and development services; clinical research in the field of the use of biologics, biosimilars, small molecules, gene-engineered cell therapy and vaccines for the treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseases and disorders of the autoimmune system, allergies, renal transplant, hypertension, chronic kidney disease, and metabolic diseases; pharmaceutical drug development services; scientific investigations for medical purposes; medical laboratory services; laboratory research services related to pharmaceuticals; advisory services relating to medical and pharmaceutical science research in the field of the use of biologics, biosimilars, small molecules, gene-engineered cell therapy and vaccines for the treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseas...
apollo therapeutics

General Information


Serial Number90798637
Word MarkAPOLLO THERAPEUTICS
Filing DateMonday, June 28, 2021
Status700 - REGISTERED
Status DateTuesday, September 26, 2023
Registration Number7172183
Registration DateTuesday, September 26, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 11, 2023

Trademark Statements


Goods and ServicesEducation services, namely, providing instruction in the field of pharmaceutical and therapeutic medical education; arranging and conducting of conferences, congresses, courses, in particular in the fields of medicine and pharmaceuticals; publishing services, namely, the publication of periodicals, books, magazines, and articles in the field of medicine, pharmaceuticals, and therapeutics; publication of periodicals, books, magazines, articles, in particular in the fields of medicine, pharmaceuticals and therapeutics
Goods and ServicesTherapeutic pharmaceuticals for the treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseases and disorders of the autoimmune system, allergies, renal transplant, hypertension, chronic kidney disease, and metabolic diseases; pharmaceutical preparations, namely biologics, biosimilars, small molecules, gene-engineered cell therapy in the nature of cells for medical use, namely autologous gene-engineered cells; medical preparations for the treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseases and disorders of the autoimmune system, allergies, renal transplant, hypertension, chronic kidney disease, and metabolic diseases
Goods and ServicesFinancial sponsorship in the form of providing financial resources to non-hospital partnerships, associations and companies, to aid in the research, development, production, import, export, retail, wholesale, promotion, commercial distribution and commercialisation of pharmaceutical, therapeutic and medicinal products and preparations
Goods and ServicesCollection of data and management of data for business purposes in connection with clinical research, testing, trial and development of pharmaceuticals, therapeutics and medical devices; computerized database management and data processing services in the field of medical, pharmaceutical and therapeutic treatment
Goods and ServicesNon-emergency and non-clinical medical and pharmaceutical consulting services related to the use of pharmaceutical preparations, namely biologics, biosimilars, small molecules, gene-engineered cell therapy and vaccines; non-emergency medical analysis services for diagnostic and treatment purposes related to the use of pharmaceutical preparations, namely biologics, biosimilars, small molecules, gene-engineered cell therapy and vaccines, provided by medical laboratories; medical analysis and examination services related to the treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseases and disorders of the autoimmune system, allergies, renal transplant, hypertension, chronic kidney disease, and metabolic diseases, provided by medical laboratories; medical treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseases and disorders of the autoimmune system, allergies, renal transplant, hypertension, chronic kidney disease, and metabolic diseases; advisory services relating to medical and pharmaceutical science, namely, medical advisory services and pharmaceutical advisory services in the field of the use of biologics, biosimilars, small molecules, gene-engineered cell therapy and vaccines for the treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseases and disorders of the autoimmune system, allergies, renal transplant, hypertension, chronic kidney disease, and metabolic diseases
Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesScientific, medical and pharmaceutical research and development services; clinical research in the field of the use of biologics, biosimilars, small molecules, gene-engineered cell therapy and vaccines for the treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseases and disorders of the autoimmune system, allergies, renal transplant, hypertension, chronic kidney disease, and metabolic diseases; pharmaceutical drug development services; scientific investigations for medical purposes; medical laboratory services; laboratory research services related to pharmaceuticals; advisory services relating to medical and pharmaceutical science research in the field of the use of biologics, biosimilars, small molecules, gene-engineered cell therapy and vaccines for the treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseases and disorders of the autoimmune system, allergies, renal transplant, hypertension, chronic kidney disease, and metabolic diseases; research and development of pharmaceutical preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 10, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, March 1, 2023
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, September 10, 2021
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateFriday, September 10, 2021
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 10, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 10, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameApollo Therapeutics LLP
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLondon SW72PG
GB

Party NameApollo Therapeutics LLP
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLondon SW72PG
GB

Party NameApollo Therapeutics LLP
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLondon SW72PG
GB

Trademark Events


Event DateEvent Description
Tuesday, September 26, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 26, 2023REGISTERED-PRINCIPAL REGISTER
Monday, August 21, 20231(B) BASIS DELETED; PROCEED TO REGISTRATION
Monday, July 10, 2023NOTICE OF ALLOWANCE CANCELLED
Monday, August 21, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 10, 2023TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, June 6, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 11, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 11, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 3, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 1, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, March 1, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 1, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, March 1, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 21, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 21, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 21, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 6, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 6, 2023NON-FINAL ACTION E-MAILED
Friday, January 6, 2023NON-FINAL ACTION WRITTEN
Thursday, November 10, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 9, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 9, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 30, 2022ASSIGNED TO EXAMINER
Tuesday, June 7, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 7, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, June 7, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 7, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 2, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 2, 2022NON-FINAL ACTION E-MAILED
Thursday, June 2, 2022NON-FINAL ACTION WRITTEN
Friday, March 18, 2022ASSIGNED TO EXAMINER
Friday, September 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 6, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 6, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 6, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 1, 2021NEW APPLICATION ENTERED